Alfasigma’s Post

This week in the pharmaceutical industry, strategic partnerships and investments come to the fore. We have compiled the most prominent developments for you. 👇 Enjoy your reading! ✅Eli Lilly announces $3bn expansion to US injectables manufacturing facility https://lnkd.in/gmFXdx92 ✅£16 million to fund UK-Switzerland life sciences research https://lnkd.in/e3ny2jYx ✅Er-Kim and Ascendis’ endocrine therapy agreement extended in Eurasia https://lnkd.in/dQYhJxhK ✅Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say https://lnkd.in/dScfnRaP ✅AIM ImmunoTech gains Netherlands patent for post-Covid fatigue therapy https://lnkd.in/dzwJUvUu #pharmanews #pharmaceuticals #strategyconsulting #fitminds

🌟 Exciting Industry Insights Alert! 🌟 Thrilled to share a thought-provoking article by Chris Bennani, Clemens Moeller, Ph.D. Satyanarayan Chandrashekhar and Sean McMaster on the future of Pharma Contract Research Organizations (CROs). Their analysis points to significant shifts on the horizon that could reshape the industry in the next 5-10 years. Key Takeaways: 1️⃣ Patient-centered clinical trial models may disrupt current value pools, creating new opportunities. 2️⃣ Adoption of digital tech & AI could revolutionize CRO operations and unlock potential value pools. 3️⃣ The market trend towards full-service vendors may impact value pools significantly. Kudos to the authors for shedding light on the evolving landscape of CROs in biopharma. Their insights urge CRO management teams to strategize for future growth and relevance. A must-read for industry professionals looking to stay ahead of the curve! 🚀🔍 #Biopharma #CROs #IndustryInsights #FutureTrends #StrategicPlanning

Cleocast: CHG’s Pioneering Pharmaceutical Research in the Spotlight (Part Four)      In the fourth and final part of this special Cleocast episode, Dr. Kareem Awad MBA , SCM CHG’s Director of Pharmaceutical Services, expands on his overview of CHG’s Pharmaceutical Department, and how it achieves exceptional results through a smart multifaceted approach. One of these strategies the department uses to remain at the forefront is its multitude of fruitful partnerships with top universities, big pharmaceutical companies, and others, granting CHG access to a wide pool of professionals, medications, and more. Watch the video to learn more about these partnerships, how they help CHG maintain its lead, how they help CHG accomplish big feats such as large-scale clinical trials, and of course, how they help the patient and streamline their journey. #CleopatraHospitalsGroup #CHG #HealthCare #Health #HealthandWellness #CleoCast #pharmaceutical #PharmaceuticalResearch #Innovation #DigitalTransformation

🔈 🔉 🔊 We are excited to announce the upcoming panel discussion focusing on the relevance of sustainability in the pharmaceutical industry. Join us as we hear from pharmaceutical experts, including Hans Christian Eder from ZETA GmbH, as they share their insights and perspectives. Check out the event details here ▶ : https://lnkd.in/dnPjtNaA Be sure to mark your calendars and join us for this important conversation 👥. #paneldiscussion #sustainability #pharmaceuticalindustry

"Esteemed Pharma Leaders," Inviting you to PharmaLytica 2024, May 30 - June 1 at HITEX, Hyderabad, for a celebration of a decade of pharmaceutical innovation. We'd like to extend a VIP invitation. Let’s connect to explore your participation in this landmark event. more details: sathik.basha@informa.com #PharmaIndustry #PharmaInnovation #Biopharma #Pharmaceuticals #MedicineDevelopment #HealthcareTech #DrugDiscovery #MedicalResearch #ClinicalTrials #PharmaConference #LabEquipment #LabAutomation #PharmaMachinery #LabInstruments #PharmaManufacturing #LabTechnology #PharmaLab #MachineryAutomation #LabTesting #LabSafety

The clinical Contract Research Organization (CRO) model is at a turning point. The industry must move towards greater use of digital tools, decentralized trials, and patient-centric approaches, creating opportunities for CROs to take on new, more strategic roles in the drug development process. These shifts are reshaping how pharmaceutical companies and CROs collaborate.   Pharmaceutical leaders must evaluate how these trends will redefine their partnerships. Explore the full report to learn how to stay ahead in this evolving landscape: https://lnkd.in/g6Ha-zYd

The countdown to CPHI Worldwide is on, and we can't wait to join industry leaders, innovators, and experts at this premier event for the pharmaceutical sector! #CPHIWorldwide #Pharmaceuticals #PharmaInnovation #PharmaNetworking #CPHI2024 #PharmaTrends #DrugDevelopment #Manufacturing #GlobalHealth

he clinical Contract Research Organization (CRO) model is at a turning point. The industry must move towards greater use of digital tools, decentralized trials, and patient-centric approaches, creating opportunities for CROs to take on new, more strategic roles in the drug development process. These shifts are reshaping how pharmaceutical companies and CROs collaborate. Pharmaceutical leaders must evaluate how these trends will redefine their partnerships. Explore the full report to learn how to stay ahead in this evolving landscape: https://bcg.smh.re/Dr4

ICYMI: 2024 was a year of transformative growth for the specialty pharmaceutical industry while 2025 looks to be a continuation of that trend. From breakthroughs in AI and evolving U.S. and EU regulations to a more focused effort on personalized patient care, significant progress has been made. Discover how AscellaHealth is uniquely positioned to help pharmaceutical manufacturers assimilate and adapt to the changing pharmaceutical landscape  and drive collaborative success through strategic partnerships in the year ahead. Read more in our latest article: https://lnkd.in/ecWvfwyf #PharmaInnovation #HealthcareTrends #AscellaHealth #RareDisease #SpecialtyPharmacy #LifeSciences

DUPHAT celebrates another year of empowering the pharmaceutical community through innovation, collaboration, and knowledge-sharing. Together, we've made strides in advancing pharmaceutical sciences and shaping the future of healthcare. Here’s to a brighter 2025 filled with groundbreaking discoveries, impactful connections, and continued excellence in the pharmaceutical industry. #DUPHAT2025 #Pharmaindustry #Pharmaceuticalexcellence #newyear2025